• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY Back to Search Results
Model Number 8888160341
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/07/2019
Event Type  malfunction  
Manufacturer Narrative
The incident sample has been requested but to date has not been received for evaluation.If the sample is received, or if additional information pertinent to the incident is obtained a follow-up report will be submitted.As part of our manufacturing process, all device history records are reviewed and approved by quality, prior to release of product.
 
Event Description
The customer reports the umbilical catheter was leaking at the umbilical stump.The catheter was removed and replaced.
 
Manufacturer Narrative
A device history review revealed no discrepancies that may have contributed to a complaint of this failure mode.All quality assurance testing performed during manufacturing was acceptable.The quality assurance review of the visual, physical and dimensional evaluation results indicated that the product met specification requirements.In addition, all dhr are reviewed for accuracy prior to product release.One used uvc catheter was returned to the plant for investigation.The sample was returned in a generic plastic bag and showed signs of use (residues of blood).The sample had a syringe attached.A visual inspection and under water test were performed on the sample and the reported condition was confirmed, a leak was identified below the strain relief.It must be noted that in-process controls (such as personnel training, incoming quality acceptance testing for raw material, 100% in process visual inspection and visual acceptance sampling) are in place to prevent nonconforming product from leaving the manufacturing operations.Based on the available information, it can be concluded that the product was manufactured according to specifications; therefore, the most probable root cause can be considered as misuse; this defect was most likely damaged during use, caused by inappropriate manipulation by the user.A corrective action is not applicable at this time.Functional testing and visual inspections are being performed according to our current quality standards and inspection procedures.This complaint will be used for qa tracking and trending purposes.
 
Manufacturer Narrative
A review of the device history record (dhr) for lot number 1812300097 indicated the product was released meeting all quality standards.All dhrs are reviewed for accuracy prior to product release.In-process procedures are also in place to prevent nonconforming product in the manufacturing process.This ensures components and finished products meet all quality inspection standards.These controls include, but are not limited to: material verification/certification processes, dimensional specifications, statistical samplings, periodic audits, process inspections, machine maintenance/operation and personnel training and certification.100% of the catheters are submitted to a pressure test which would identify this issue in the catheter.The actual device was not returned for evaluation.Without the device or a representative sample being provided, a more comprehensive investigation could not be performed.The reported issue could not be replicated.However, two (2) digital images (photographs) were provided for evaluation.Visual evaluation of the photos was performed.The first photo shows a pouch with the batch and the expiration date.The second photo shows the reference number and catheter information.It is not possible determine the reported condition with the evidence provided.Potential causes of the reported condition could include defective material, operator failed to follow process or inspection procedures, user did not follow instructions, machine malfunction, or measurement specifications.Information is insufficient to determine whether any of these scenarios occurred.A probable cause could not be identified.The reported customer complaint could not be confirmed.A root cause could not be determined.This complaint will be used for tracking and trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
5.0FR URETHANE UMB CATH
Type of Device
CATHETER, UMBILICAL ARTERY
Manufacturer (Section D)
COVIDIEN
edificio b20 calle #2 zona fra
alajuela
CS 
MDR Report Key8339494
MDR Text Key136152200
Report Number3009211636-2019-00642
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup,Followup
Report Date 06/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/14/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number8888160341
Device Catalogue Number8888160341
Device Lot Number1812300097
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/22/2019
Date Manufacturer Received02/07/2019
Patient Sequence Number1
-
-